Our study demonstrated that p16 knockout may alter β‐Alanine metabolism and pyrimidine metabolism in the kidney, which may suppress chronic renal inflammation, inhibit the NF‐κB pathway, and ultimately alleviate obesity‐related renal fibrosis. This evidence concerns the gene CDKN2A and obesity due to melanocortin 4 receptor deficiency.